Who makes Lamotrigine ER tablet 50mg?

Lamotrigine ER tablet 50mg is developed by Alembic Pharmaceuticals Ltd..

What development phase is Lamotrigine ER tablet 50mg in?

Lamotrigine ER tablet 50mg is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Lamotrigine ER tablet 50mg

Alembic Pharmaceuticals Ltd. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Lamotrigine ER tablet 50mg
Also known as	Reference- Lamictal® XRTM (Lamotrigine) ER tablet 50mg, Lamictal 50mg
Sponsor	Alembic Pharmaceuticals Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Lamotrigine ER tablet 50mg CI brief — competitive landscape report
Lamotrigine ER tablet 50mg updates RSS · CI watch RSS
Alembic Pharmaceuticals Ltd. portfolio CI